Do-Wan Lee1, Hwon Heo2, Chul-Woong Woo3, Dong-Cheol Woo2,3, Jeong-Kon Kim1, Kyung-Won Kim1, Dong-Hoon Lee4. 1. Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. 2. Department of Convergence Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul 05505, Korea. 3. Convergence Medicine Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul 05505, Korea. 4. Department of Radiation Convergence Engineering, College of Health Sciences, Yonsei University, Wonju, Gangwondo 26493, Korea.
Abstract
BACKGROUND: Glutamate-weighted chemical exchange saturation transfer (GluCEST) is a useful imaging tool that can be used to detect changes in glutamate levels in vivo and could also be helpful in the diagnosis of brain myelin changes. We investigated glutamate level changes in the cerebral white matter of a rat model of cuprizone-administered demyelination and remyelination using GluCEST. METHOD: We used a 7 T pre-clinical magnetic resonance imaging (MRI) system. The rats were divided into the normal control (CTRL), cuprizone-administered demyelination (CPZDM), and remyelination (CPZRM) groups. GluCEST data were analyzed using the conventional magnetization transfer ratio asymmetry in the corpus callosum. Immunohistochemistry and transmission electron microscopy analyses were also performed to investigate the myelinated axon changes in each group. RESULTS: The quantified GluCEST signals differed significantly between the CPZDM and CTRL groups (-7.25 ± 1.42% vs. -2.84 ± 1.30%; p = 0.001). The increased GluCEST signals in the CPZDM group decreased after remyelination (-6.52 ± 1.95% in CPZRM) to levels that did not differ significantly from those in the CTRL group (p = 0.734). CONCLUSION: The apparent temporal signal changes in GluCEST imaging during demyelination and remyelination demonstrated the potential usefulness of GluCEST imaging as a tool to monitor the myelination process.
BACKGROUND:Glutamate-weighted chemical exchange saturation transfer (GluCEST) is a useful imaging tool that can be used to detect changes in glutamate levels in vivo and could also be helpful in the diagnosis of brain myelin changes. We investigated glutamate level changes in the cerebral white matter of a rat model of cuprizone-administered demyelination and remyelination using GluCEST. METHOD: We used a 7 T pre-clinical magnetic resonance imaging (MRI) system. The rats were divided into the normal control (CTRL), cuprizone-administered demyelination (CPZDM), and remyelination (CPZRM) groups. GluCEST data were analyzed using the conventional magnetization transfer ratio asymmetry in the corpus callosum. Immunohistochemistry and transmission electron microscopy analyses were also performed to investigate the myelinated axon changes in each group. RESULTS: The quantified GluCEST signals differed significantly between the CPZDM and CTRL groups (-7.25 ± 1.42% vs. -2.84 ± 1.30%; p = 0.001). The increased GluCEST signals in the CPZDM group decreased after remyelination (-6.52 ± 1.95% in CPZRM) to levels that did not differ significantly from those in the CTRL group (p = 0.734). CONCLUSION: The apparent temporal signal changes in GluCEST imaging during demyelination and remyelination demonstrated the potential usefulness of GluCEST imaging as a tool to monitor the myelination process.
Entities:
Keywords:
chemical exchange saturation transfer; cuprizone; demyelination; glutamate; remyelination
Authors: Rong Zhou; Puneet Bagga; Kavindra Nath; Hari Hariharan; David A Mankoff; Ravinder Reddy Journal: Cancer Res Date: 2018-08-02 Impact factor: 12.701
Authors: Jeroen J G Geurts; Ilona E W Reuling; Hugo Vrenken; Bernard M J Uitdehaag; Chris H Polman; Jonas A Castelijns; Frederik Barkhof; Petra J W Pouwels Journal: Magn Reson Med Date: 2006-03 Impact factor: 4.668
Authors: Kejia Cai; Mohammad Haris; Anup Singh; Feliks Kogan; Joel H Greenberg; Hari Hariharan; John A Detre; Ravinder Reddy Journal: Nat Med Date: 2012-01-22 Impact factor: 53.440
Authors: Kristin P O'Grady; Sanjana Satish; Quinn R Owen; Bailey A Box; Francesca Bagnato; Anna J E Combes; Sarah R Cook; Holly James Westervelt; Haley R Feiler; Richard D Lawless; Asha Sarma; Shekinah D Malone; Josephine M Ndolo; Keejin Yoon; Richard D Dortch; Baxter P Rogers; Seth A Smith Journal: Front Neurol Date: 2022-02-25 Impact factor: 4.003
Authors: Martin Zirngibl; Peggy Assinck; Anastasia Sizov; Andrew V Caprariello; Jason R Plemel Journal: Mol Neurodegener Date: 2022-05-07 Impact factor: 18.879